Resources
Sources
MS News (Y!)
- Research and Markets: Siponimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022 55 min 58 sec old
- Research and Markets: PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022 1 day 21 min old
- Research and Markets: PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 1 day 48 min old
- New grant to fund multiple sclerosis trials, research 1 day 10 hours old
- Research and Markets: PharmaPoint: Multiple Sclerosis - Germany Drug Forecast and Market Analysis to 2022 2 days 1 hour old
- Research and Markets: PharmaPoint: Multiple Sclerosis - France Drug Forecast and Market Analysis to 2022 2 days 1 hour old
- Research and Markets: PharmaPoint Drug Evaluation Report - Tysabri (Multiple Sclerosis) - Forecast and Market Analysis ... 2 days 1 hour old
- Research and Markets: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022 2 days 8 hours old
- XenoPort to drop multiple sclerosis drug, shares fall 3 days 1 hour old
- Fighting multiple sclerosis one step at a time 3 days 5 hours old
- Research and Markets: Gilenya (Multiple Sclerosis) - Forecast and Market Analysis to 2022 6 days 5 hours old
- Research and Markets: PharmaPoint Analysis: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022 1 week 2 hours old
- Research and Markets: Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2022 1 week 3 hours old
- PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 1 week 7 hours old
- Research and Markets: Laquinimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022 1 week 7 hours old
- Research and Markets: Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022 1 week 1 day old
- Research and Markets: Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022 1 week 1 day old
- Research and Markets: BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022 1 week 1 day old
- Research and Markets: Betaseron/Betaferon (Multiple Sclerosis) - Forecast and Market Analysis to 2022 1 week 1 day old
- Research and Markets: Lemtrada (Multiple Sclerosis) - Forecast and Market Analysis to 2022 1 week 1 day old
- PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022 1 week 1 day old
- PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022 1 week 1 day old
- PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022 1 week 1 day old
- Research and Markets: PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022 1 week 1 day old
- Research and Markets: Multiple Sclerosis Partnering 2007-2013 Out Now 1 week 2 days old
Multiple Sclerosis Alerts - Google
- The Clinical Relevance of Force Platform Measures in <b>Multiple</b> <b>...</b> 1 hour 29 min old
- Beaver Creek golf tourney to benefit Can Do <b>Multiple Sclerosis</b> <b>...</b> 1 hour 29 min old
- An Introduction to <b>Multiple Sclerosis</b> - Medical Animation Short <b>...</b> 1 hour 29 min old
- AOL On - Healing Yoga to Alleviate <b>Multiple Sclerosis</b> Pains 1 hour 29 min old
- <b>Multiple Sclerosis</b> - American Academy of Family Physicians 1 hour 29 min old
- <b>Multiple Sclerosis</b> Matters Fundraiser Group | Facebook 1 hour 29 min old
- Thousands walk in Eisenhower Park to fund research for <b>multiple</b> <b>...</b> 1 hour 29 min old
- XenoPort Inc Drops <b>Multiple Sclerosis</b> Drug After - BioSpace 1 hour 29 min old
- The clinical potential of blood-proteomics in <b>multiple sclerosis</b> 1 hour 29 min old
- Another <b>Multiple Sclerosis</b> Winner for Biogen - The Motley Fool 1 hour 29 min old
- Pride of Reading nomination for Erica Key 1 hour 52 min old
- Jack Osbourne on MS diagnosis: 'My parents worry so much' 1 hour 52 min old
- ASA Automotive Systems Plans Donation to Support MOMS 1 hour 52 min old
- High winds couldn't keep walkers away from Walk MS 1 hour 52 min old
- Marcus football coach Bryan Erwin tackles MS charity bike ride 1 hour 52 min old
- Biogen Idec appoints Spyros Artavanis-Tsakonas chief scientific officer 1 hour 52 min old
- NJ changes parking program for disabled 1 hour 52 min old
- Building up to be an engineer 1 hour 52 min old
- Runner thanks pupils for their support 1 hour 52 min old
- WAAY 31 FirstNews at 4: Thursday, May 23, 2013 1 hour 52 min old
- Stortford cake bake cash boosts <b>Multiple Sclerosis</b> Society 2 days 1 hour old
- Summer sports party to raise funds for <b>multiple sclerosis</b> research 2 days 1 hour old
- Jack Osbourne talks with Dr. Oz about his <b>multiple sclerosis</b> and Paleo diet 2 days 1 hour old
- William P. “Bill” VanNatta - SWNews4u.com 2 days 1 hour old
- XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for <b>...</b> 2 days 1 hour old
Multiple Sclerosis Research
- Prognostic risk estimates in MS 9 hours 34 min old
- The publishing process can be frustrating 9 hours 56 min old
- Rant-of-the-week: explained 9 hours 58 min old
- Cloning humans is possible 9 hours 59 min old
- Who is the MouseDoctor....Green Cross Code Man or Honey Monster? 16 hours 8 min old
- Biogen-Idec submits application to FDA for Peg-interferon beta-1a in MS 1 day 6 hours old
- Pathological crying and laughing in MS 1 day 11 hours old
- Stress predicting active lesions on MRI 1 day 17 hours old
- Phenytoin in Acute Optic Neuritis: trial recruitment update 1 day 18 hours old
- Come on Team G....Less time Blogging More results! 1 day 23 hours old
- Raltegravir in MS: recruitment update 2 days 11 hours old
- Failing NHS Services 2 days 11 hours old
- XenoPort to drop Arbaclofen for MS spasticity 2 days 19 hours old
- Destructive white matter changes in early MS 3 days 11 hours old
- Viral Triggers of Relapse 3 days 11 hours old
- Exercise is good for you 4 days 9 hours old
- Japanes Month of Birth Effect Difference from Europeans 4 days 9 hours old
- Brain shrinking occurs early in MS 5 days 5 hours old
- Safety of Fampridine one year on 5 days 12 hours old
- Measuring Australian MSers 5 days 12 hours old
- Use It of Lose It. 6 days 5 hours old
- Is the NHS over? 6 days 7 hours old
- Another role for CD8 T cells 6 days 9 hours old
- Should Project VD be Project M? 1 week 8 hours old
- More targets for remyelination 1 week 9 hours old
Shades of Amber
- Willing To Wait 18 hours 42 min old
- Where The Battle Begins 10 weeks 2 days old
- Taking A Break 13 weeks 17 hours old
US National Multiple Sclerosis Society National News
- MS Trial Alert: Investigators Nationwide Recruiting People with All Types of MS for Early, Phase I Study to Determine Safety of Experimental Antibody 23 hours 1 min old
- UPDATED: Clinical Trial Results Announced in Study of Peginterferon Beta-1a - Company Submits Application to FDA 2 days 33 min old
- Studies Report Progress Understanding What Drives Repair of the Brain’s Insulating Myelin, Which is Damaged by MS 2 weeks 1 day old
- Study Finds that the Incidence of MS Appears to be Higher in African American Women Than in Caucasians, Contradicting Previous Findings 2 weeks 2 days old
- Bimbo Bakeries USA and Flowers Foods “Summer Bun” Program Benefits National MS Society 2 weeks 5 days old
- Positive Results Announced for Aubagio in Phase III Study of People at High Risk for MS 3 weeks 6 days old
- Results Published from Phase II Trial of Daclizumab in Relapsing MS 4 weeks 1 hour old
- Cases of PML Reported in People Taking Fumarate-based Treatments for Psoriasis - No cases reported in People with MS Taking Related Product, Tecfidera 4 weeks 19 hours old
- MS Trial Alert: Drug Study at NIH Recruiting People with Primary-Progressive MS 4 weeks 2 days old
- $18 Million in New Research Projects Launched To Stop MS, Restore Function and End It Forever - Part of 2013 investment of over $47 million in cutting-edge research projects 4 weeks 6 days old
- Meeting of MS Outcome Assessments Consortium and FDA Clears Pathway for New Tool for Clinical Trials in MS, Particularly Progressive Forms 5 weeks 3 hours old
- $18 Million in New Research Projects Launched To Stop MS, Restore Function and End It Forever - Part of 2013 investment of over $47 million in cutting-edge research projects 5 weeks 1 day old
- National MS Society statement concerning the Boston Marathon 5 weeks 2 days old
- Month of Birth May Influence Risk of MS by Promoting Changes in Immune System Development 5 weeks 3 days old
- MS Trial Alert: Drug Study at NIH Recruiting People with Secondary-Progressive MS 5 weeks 3 days old
- New Study Reports That an Online Community of People with MS May Be Used to Study the Disease 5 weeks 6 days old
- National MS Society Partners with the University of Miami and Accera, Inc. to Test Novel “Medical Food” for MS Cognitive Impairment 5 weeks 6 days old
- Emerging Therapies, Risk Factors and Other MS Research News from American Academy of Neurology Meeting 6 weeks 20 hours old
- Canbex Therapeutics Raises $ 3.2 million to Develop Treatment for Debilitating Muscle Spasms Associated with MS 6 weeks 1 day old
- Annette Funicello, beloved 1950s Disney “Mouseketeer” and 1960s movie star, died April 8th at the age of 70 from complications of multiple sclerosis 6 weeks 3 days old
- SOCIETY CO-SPONSORS RALLY FOR MEDICAL RESEARCH 6 weeks 6 days old
- Sam’s Club: Maximizing a local relationship and making a nationwide difference 6 weeks 6 days old
- The National MS Society Commends and Supports President Obama’s Announced Brain Research Initiative 7 weeks 2 days old
- FDA Approves Twice a Day Capsules Called Tecfidera™ (formerly called BG-12) for Relapsing MS 8 weeks 19 hours old
- Oxford’s Professor George Ebers Wins 2013 John Dystel Prize for MS Research: Revolutionized our understanding of MS 9 weeks 2 hours old
MS Research Australia
- $1 million funding for multiple sclerosis research 1 day 17 hours old
- Early treatment with interferon-beta may preserve cognition 3 days 18 hours old
- USA scientists succeed in deriving human embryonic stem cells 6 days 18 hours old
- NSW Senate Inquiry advocates for medical use of cannabis 1 week 14 hours old
- Cognition and fatigue predict unemployment in people with MS 1 week 1 day old
- Can stem cells help Kiss Goodbye to MS 1 week 3 days old
- New dietary research looks into fatty acids, vitamins and lipids in MS 2 weeks 6 days old
- Long-term outcomes improving for people with MS 5 weeks 17 hours old
- Making myelin from skin cells holds promise for repair in MS 5 weeks 2 days old
- Experimental treatment daclizumab shows promise in phase II trial results 6 weeks 13 hours old
- A new treatment which blocks sodium channels successful in laboratory models of MS 6 weeks 1 day old
- Canadian researchers reveal how bone marrow transplants for MS re-set the immune system 7 weeks 1 day old
- Fatigue: the most significant factor influencing employment in MS 7 weeks 2 days old
- FDA approves dimethyl fumarate (Tecfidera) a new oral treatment for MS in the US 8 weeks 12 hours old
- Participants wanted for study of depression and anxiety in newly diagnosed people with MS 8 weeks 1 day old
- The effect of sun exposure on neurodegeneration 8 weeks 3 days old
- Another genetic clue to MS susceptibility 9 weeks 16 hours old
- Online mindfulness programme for people with MS 9 weeks 1 day old
- Natalizumab as a treatment option for people with paediatric MS 10 weeks 1 day old
- High salt diet linked to autoimmunity 10 weeks 3 days old
- Australian researchers hunt down genetic changes that cause MS 10 weeks 6 days old
- International MS community meets to fast track developments for Progressive MS 11 weeks 1 day old
- CCSVI Research Round-up March 2013 11 weeks 3 days old
- Next 30 newsletter - March issue - available now 11 weeks 3 days old
- Protein build-up may prevent repair in MS 12 weeks 6 days old
Not Quite Right!
- Recovering from Multiple Sclerosis - Book Review 2 days 5 hours old
- Google Music Hits Australia and New Zealand 6 weeks 12 hours old
- Mobility equals Independence for the Disabled 11 weeks 5 days old
- Teriflunomide trial comes to an end 15 weeks 6 days old
PubMed
- multiple sclerosis; +56 new citations 4 days 39 min old
- multiple sclerosis; +98 new citations 1 week 5 days old
- multiple sclerosis; +108 new citations 2 weeks 6 days old
- multiple sclerosis; +116 new citations 4 weeks 39 min old
- multiple sclerosis; +87 new citations 5 weeks 1 day old
- multiple sclerosis; +68 new citations 6 weeks 2 days old
- multiple sclerosis; +97 new citations 7 weeks 2 days old
- multiple sclerosis; +77 new citations 8 weeks 3 days old
- multiple sclerosis; +55 new citations 9 weeks 4 days old
- multiple sclerosis; +70 new citations 10 weeks 4 days old
- multiple sclerosis; +71 new citations 11 weeks 5 days old
- multiple sclerosis; +77 new citations 12 weeks 6 days old
- multiple sclerosis; +90 new citations 14 weeks 1 hour old
- multiple sclerosis; +98 new citations 15 weeks 1 day old
- multiple sclerosis; +84 new citations 16 weeks 2 days old
Wheelchair Kamikaze
- Tecfidera (BG 12) And PML 1 week 12 hours old
- Can Anti-HIV Drugs Stop MS? 2 weeks 3 days old
- Anger Mismanagement 5 weeks 1 day old
- Hype or Hope? Much Touted Oral MS Drug Tecfidera (BG 12) Approved byFDA. 7 weeks 3 days old
- Bits and Pieces: Getting on with Life Edition 9 weeks 2 days old
- The Greek, In Memoriam 11 weeks 11 hours old
- Entering the Twilight Zone 12 weeks 6 days old
- Big Pharma, Bad Medicine 15 weeks 4 days old
CCSVI - Google Alerts
- <b>CCSVI</b> dead? Not so fast! 3 weeks 23 hours old
- The only thing liberated was their wallets 3 weeks 5 days old
- MS Patients Shouldn't Rush Into Liberation Therapy - <b>Venous</b> <b>...</b> 3 weeks 5 days old
- Liberation therapy for MS not very liberating it seems now 4 weeks 3 days old
- Annette Funicello's Desperate Last-Ditch MS Treatment 6 weeks 2 days old
- Controversial No More – Study Shows Much Hyped Multiple Sclerosis <b>...</b> 7 weeks 3 days old
- Brain hemodynamic changes associated with <b>chronic cerebrospinal</b> <b>...</b> 7 weeks 5 days old
- Angioplasty Does Not Benefit MS Patients, UB Study Finds 7 weeks 5 days old
- UTHealth research: low incidence of <b>venous insufficiency</b> in MS 7 weeks 5 days old
- Vein-opening MS treatment shows no benefit in trials 7 weeks 5 days old
- 'Liberation therapy' may make MS worse 7 weeks 5 days old
- MS patients did not benefit from <b>CCSVI</b> intervention 9 weeks 5 days old
- Vitamin D3 plays significant role in slowing degenerative process in <b>...</b> 9 weeks 6 days old
- <b>CCSVI</b> Research Round-up March 2013 | MS Research Australia 9 weeks 6 days old
- Low incidence of <b>venous insufficiency</b> in multiple sclerosis 9 weeks 6 days old
- Feeds for Google Alerts 9 weeks 6 days old
CCSVI - (Y!)
- CCSVI dead? Not so fast! 3 weeks 1 day old
- The only thing liberated was their wallets 3 weeks 5 days old
- LARRY LITTLE | Three who made a difference 5 weeks 5 days old
- Vein-opening for multiple sclerosis investigations continues 8 weeks 3 days old
- Vein-opening for multiple sclerosis investigations continue 8 weeks 3 days old
- MS patients do not benefit from CCSVI intervention, landmark pilot study finds 9 weeks 1 hour old
- The 6th Floor Blog: A ‘Sham Procedure’ Leads to Disappointing M.S. News 9 weeks 23 hours old
- Study casts doubt on MS treatment 9 weeks 3 days old
- ’Liberation’ treatment offers no improvement for MS patients, may do harm: study 9 weeks 3 days old
- Opening Veins Does Not Help Multiple Sclerosis Patients 9 weeks 4 days old
- Interventional endovascular therapy is safe but does not improve MS outcomes: Study 9 weeks 5 days old
- Vein-opening MS treatment shows no benefit in trials 9 weeks 5 days old
- ‘Liberation’ treatment offers no sustained improvement for MS patients: study 9 weeks 5 days old
- ‘Liberation’ treatment offers no benefit for MS patients: study 9 weeks 5 days old
- MS ‘Liberation’ treatment offers no help, may harm: study 9 weeks 5 days old
- 'Liberation' treatment offers no sustained improvement for MS patients: study 9 weeks 5 days old
- 'Liberation' treatment offers no improvement for MS patients, may do harm: study 9 weeks 5 days old
- 'Liberation' treatment offers no sustained improvement for MS patients: study 9 weeks 6 days old
- MS patients did not benefit from CCSVI intervention 9 weeks 6 days old
- FREE Brain Health Fair Coming to San Diego Saturday, March 16 10 weeks 2 days old
- Low incidence of venous insufficiency in multiple sclerosis 10 weeks 6 days old
- UTHealth research: Low incidence of venous insufficiency in MS 10 weeks 6 days old
- Living with MS: Local woman details struggle 14 weeks 3 days old
- Living with MS: Local woman details struggle 14 weeks 3 days old
Multiple Sclerosis Society of Queensland
- READY Resilience Program 4 weeks 1 day old
- NDIS needs to come to Queensland! 4 weeks 6 days old
- Celebrate MS Awareness Month with MS Ambassador Mayor Pisasale 5 weeks 6 days old
- Heartmoves for MS - Ipswich classes 8 weeks 1 day old
- Callout for Living Positively Stories 8 weeks 3 days old
- NDIS is passed in Parliament 8 weeks 6 days old
- MS Heroes nominations period extended by one week 9 weeks 6 days old
- Volunteers Needed for Bunnings M to S Sausage Sizzle 9 weeks 6 days old
- MS Queensland Entertainment Books 10 weeks 9 hours old
- After- hours Yoga 6 week program 10 weeks 4 days old
- MS Heroes 2013 nominations close THIS FRIDAY 10 weeks 4 days old
- After- hours Yoga 8 week program 10 weeks 4 days old
- MS Heroes 2013 nominations close NEXT FRIDAY 10 weeks 6 days old
- NDIS update March 2013 11 weeks 3 hours old
- Information Session for people newly diagnosed with MS 11 weeks 4 days old
- Ipswich Information Session for people living with MS 11 weeks 4 days old
- Only 2 weeks left to nominate your MS Hero 12 weeks 3 hours old
- Who is your MS Hero? 12 weeks 4 days old
- NDIS update February 2013 12 weeks 6 days old
- MS Heroes awards now open! 14 weeks 1 day old
- Introducing after hours services to Dutton Park Clinic 14 weeks 6 days old
- 2013 'Fatigue Self-Management' & 'Working with MS' workshops 14 weeks 6 days old
MedPage Today Multiple Sclerosis
- Analysis: Few Surprises with New MS Drugs 8 weeks 19 hours old
- Biogen's MS Drug Tecfidera Wins FDA Nod 8 weeks 20 hours old
- MS Research Gears Up for New Drugs 8 weeks 1 day old
- MRI for Low Back Problems Deemed 'Overused' 8 weeks 1 day old
- Testosterone Affects MS Outcomes in Men 9 weeks 4 hours old
- Vein Surgery for MS Fails in First Controlled Trial 9 weeks 5 days old
- PML Not Fatal if Caught Early 10 weeks 3 days old
- PML Not Fatal if Caught Early 10 weeks 3 days old
- Hormone Pulse Tx May Lessen MS Relapse 10 weeks 3 days old
- Hormone Pulse Tx May Lessen MS Relapse 10 weeks 3 days old
- Lab Notes: Salt May Promote MS 10 weeks 5 days old
- Mental Deficit in MS Tied to White Matter Damage 10 weeks 6 days old
- Brain Infection Relapses Tied to Peripheral Nerves 10 weeks 6 days old
- Fog Lifting in MS Gender Enigma 11 weeks 1 day old
- Tysabri May Be Option for Kids with MS 13 weeks 1 day old
- Clinical Notes: Internet Flu Tracker Flops 13 weeks 3 days old
- Panel Gives Mixed Review to MRI Contrast 13 weeks 6 days old
- FDA Skeptical of MRI Contrast Agent in Babies 14 weeks 22 hours old
- MS Patient Dies from Anti-Drug Antibodies 14 weeks 4 days old
- New MRI Methods May Improve MS Evaluation 15 weeks 5 days old
- Obesity Raises MS Risk in Girls 16 weeks 20 hours old
- Monthly MS Drug Wins in Trial 16 weeks 6 days old
Overcoming Multiple Sclerosis
- An interesting time to have MS 10 weeks 3 days old
- Overcoming Secondary Progressive MS Is Possible 16 weeks 6 days old
- Seeing MS in a different light 19 weeks 3 days old
- Having Happy Holidays 22 weeks 3 days old
- Kaybe’s menu for a deliciously healthy and stress-free Christmas dinner 24 weeks 1 day old
Perspective is everything
- Flexibility 10 weeks 5 days old
MS Buzz Blog
MS-ing about
The Goss - Linux MS'er
